Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure [2] (multiple letters)

Annals of Internal Medicine

Volumn 142, Issue 5, 2005, Pages 386-389

  McClellan, Mark B ^a   Loeb, Jerod M ^b   Clancy, Carolyn M ^c   Francis, Gary S ^d   Jacobs, Alice K ^e   Kizer, Kenneth W ^f   O'Kane, Margaret E ^g   Wolk, Michael J ^h   Peeters, Michael J ⁱ   Tsikouris, James P ⁱ   Regier, Loren D ^j   Jensen, Brent ^j   Lee, Victor C ^k   Rhew, David C ^k   Braunstein, Glenn D ^l  

^a Center for Medicare and Medicaid Services   (United States)

^b Jt Commn Accreditation H   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^d Heart Failure Society of America   (United States)

^e AMERICAN HEART ASSOCIATION   (United States)

^f NATIONAL QUALITY FORUM   (United States)

^g NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^h AMERICAN COLLEGE OF CARDIOLOGY   (United States)

ⁱ TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^j Saskatoon City Hospital   (Canada)

^k Zynx Health   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; DRUG CONTRAINDICATION; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LETTER; MEDICARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; UNITED STATES;

EID: 20044366548     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-5-200503010-00017     Document Type: Letter

References (0)